<DOC>
	<DOC>NCT02205879</DOC>
	<brief_summary>The study hypothesis is: Pregabalin is superior to placebo in preventing relapse to drinking and reducing drinking severity</brief_summary>
	<brief_title>Pregabalin for Alcohol Dependence</brief_title>
	<detailed_description>This is a two cell double blind placebo controlled randomized clinical trial of pregabalin for alcohol dependence</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Alcohol Dependence by ICDX criteria Severe comorbid psychiatric and somatic diseases</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>pregabalin</keyword>
	<keyword>patients</keyword>
	<keyword>treatment</keyword>
</DOC>